• Community Events
  • Home
  • Employment
  • Local
    • Central San Diego
    • North County
    • East County
    • South Bay
    • Northeastern
    • Riverside County
  • Entertainment
    • Music
    • Television
    • Art
    • Theater
    • Film
    • Events
    • Theme Parks
    • Podcast/Radio
    • Museums
    • Books
  • Business
  • National
  • Politics
  • Science & Technology
    • Computer
    • Science
    • Space
  • Sports
  • Environment
    • Clean Air
    • Climate change
    • Land
    • Ocean
    • Pollution
    • Recycling
  • Health
    • Health Business
    • Health Education
    • Medical
  • Lifestyle
    • Food
    • Lifestyle
    • Travel
    • Senior Life
    • Society

San Diego County News

Independent publication serving San Diego County

Predicting long COVID-19 at initial point of diagnosis

January 23, 2022 By sdcnews

By Newswise 

Seattle, WA–A significant portion of people who contract the SARS-CoV-2 virus – some estimates suggest more than 40 percent – suffer chronic effects known as Post Acute Sequelae of COVID-19 (PASC), commonly referred to as long COVID. 

PASC symptoms include fatigue, brain fog, loss of taste and smell, shortness of breath, and more.

Now, researchers have identified several factors that can be measured at the initial point of COVID-19 diagnosis that anticipate if a patient is likely to develop long COVID. These “PASC factors” are the presence of certain autoantibodies, pre-existing Type 2 diabetes, SARS-CoV-2 RNA levels in the blood, and Epstein-Barr virus DNA levels in the blood. 

“Identifying these PASC factors is a major step forward for not only understanding long COVID and potentially treating it, but also which patients are at highest risk for the development of chronic conditions,” said ISB President, Dr. Jim Heath, co-corresponding author of a research paper that will be published by the journal Cell. “These findings are also helping us frame our thinking around other chronic conditions, such as post-acute Lyme syndrome, for example.”

Additionally, researchers found that mild cases of COVID-19, not just severe cases, are associated with long COVID. They also suggest that administering antivirals very early in the disease course may potentially prevent some PASC. 

“Long COVID is causing significant morbidity in survivors of COVID-19, yet the pathobiology is poorly understood,” said Dr. Jason Goldman, co-corresponding author of the paper and an infectious disease expert at Swedish. “Our study pairs clinical data and patient-reported outcomes with deep multi-omic analyses to unravel important biological associations that occur in patients with PASC. Certain findings such as the low cortisol state in patients with long COVID have potential to translate rapidly to the clinic. Our results form an important foundation for the development of therapeutics to treat long COVID.” 

Researchers collected blood and swab samples from 309 COVID-19 patients at different time points to perform comprehensive phenotyping which was integrated with clinical data and patient-reported symptoms to carry out a deep multi-omic, longitudinal investigation. 

A key finding from the study deals with viral load, which can be measured near diagnosis to predict long COVID symptoms. “We found that early blood viral measurements are strongly associated with certain long COVID symptoms that patients will develop months later,” said Dr. Yapeng Su, a co-first and co-corresponding author of the paper. 

In addition, researchers found the Epstein-Barr virus (EBV) – a virus that infects 90 percent of the human population and is normally inactive in the body after infection – is reactivated early on after SARS-CoV-2 infection, which is significantly associated with future long COVID symptoms. “This may be related to immune dysregulation during COVID-19 infection,” Su added. 

The team also found that PASC is anticipated by autoantibodies (which are associated with autoimmune diseases like lupus) at diagnosis and that as autoantibodies increase, protective SARS-CoV-2 antibodies decrease. This suggests a relationship between long COVID, autoantibodies, and patients at elevated risk of re-infections. 

“Many patients with high autoantibodies simultaneously have low (protective) antibodies that neutralize SARS-CoV-2, and that’s going to make them more susceptible to breakthrough infections,” said Daniel Chen, a co-first author of the paper. 

The research project was a collaboration between ISB, Providence, Swedish the University of Washington, Fred Hutchinson Cancer Research Center, Stanford, UCLA, UCSF, and others.

40

SHARES
Share on Facebook
Tweet
Follow us

Comments

comments

Filed Under: Health, Medical Tagged With: Health, Medical


Support Independent Journalism



Trending

  • Feds seize more than half a million dollars worth of fentanyl
  • Poway fire contained at 25 acres
  • Man arrested on suspicion of arson at the Buena Vista Lagoon
  • CAL FIRE hits peak staffing for wildfire this summer
  • County health extends water contact closure to Imperial Beach shoreline

Advertisement

Good Sam Travel Assist

Advertisement

Start LLC today at incorporate.com

Education

UC San Diego Extended Studies identifies top 10 jobs post COVID-19 pandemic

San … [Read More...]

Environment

Oceanside enacts Level 2 Drought Reduction actions for residents and businesses

By … [Read More...]

Science & Technology

A quarter of the world’s internet users rely on infrastructure at high risk of attack

By … [Read More...]

Advertisement

Independence Day Savings! Save up to $25◊ off our Fees on Flights Use Coupon USA25.

Advertisement

Stacy Adams

Advertisement

Summer Membership offer

Advertisement

Naturepedic

Categories

  • About Us
  • Archive
  • Community Events
  • Contact Us
  • Employment
  • Private Policy
  • Terms of Service

Follow @SanCounty

Privacy Policy

Terms of service

Copyright © 2022 San Diego County News